VivoSeq
Other

Homeostasis

0

Pipeline Programs

2

Active Trials

3

Companies Involved

Homeostasis is an early-stage landscape with 0 programs across 3 companies. The most active players are Idorsia Pharmaceuticals Ltd., Takeda, Merck & Co..

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

83/100

Attrition Rate

11/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

28

clinical trials

Completed20 · 71%
Terminated2 · 7%
Unknown status2 · 7%
Not yet recruiting1 · 4%
Recruiting1 · 4%
Withdrawn1 · 4%
Other1 · 4%

Trial Activity

28 trials

Role of BCAA in Glucose Homeostasis
Not yet recruiting·MMaastricht University·Phase 4·NCT05836350·20 enrolled
The Effects of N-acetylcysteine on Performance and Redox Homeostasis
Completed··Phase 2·NCT03121222·36 enrolled
CYP3A4 Activity and Mineral Homeostasis
Completed·UUniversity of Washington·Phase 1·NCT02019875·92 enrolled
Aldosterone and Glucose Homeostasis
Completed·VVanderbilt University·N/A·NCT00732160·34 enrolled
Effect of Dexlansoprazole on Bone Homeostasis
Completed·Takeda logoTakeda·Phase 1·NCT01216293·115 enrolled
Extragonadal Effects of hCG on Calcium Homeostasis
Completed··Phase 1·NCT03418896·12 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)